Nickel, Kathrin
Heinrich, Sven P.
Beringer, Malina
Endres, Dominique
Runge, Kimon
Küchlin, Sebastian
Maier, Simon
Bach, Michael
Domschke, Katharina
Tebartz van Elst, Ludger
Friedel, Evelyn B. N.
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 28 March 2024
Accepted: 1 November 2024
First Online: 15 November 2024
Declarations
:
: KN, SPH, MBa, DE, KR, SK, SM, MBe, EF: no conflict of interest. LTvE: Advisory boards, lectures, or travel grants within the last 3 years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics. KD: Formerly: Steering Committee Neurosciences and speaker honoraria, Janssen-Cilag, within the last three years.
: The Ethics Committee of the University Medical Center Freiburg (Approval ID: 314/18) approved the study. All participants gave written informed consent to participate.